関連する実験動画
Updated: May 19, 2026
08:35
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
高血圧に対する新薬,新処置,新器具
Stéphane Laurent1, Markus Schlaich, Murray Esler
1Department of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Paris, France. stephane.laurent@egp.aphp.fr
Lancet (London, England)
|August 14, 2012
まとめ
耐性高血圧の治療は依然として困難です. 新薬やバーロ受容体刺激や腎不全などの革新的な装置は,新しい治療法を提供しているが,厳格な臨床評価が必要である.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- 医療機器 医療機器について
背景:
- 耐性高血圧は,効果的な血圧管理に重大な課題をもたらします.
- 既存の抗高血圧薬やライフスタイルの介入には限界があります.
- 治療が難しい高血圧の患者に新しい治療戦略が必要である.
研究 の 目的:
- 耐性高血圧に対する有望な治療の代替案を探求する.
- 新薬学的薬剤と革新的な手順/デバイスベースの治療法をレビューする.
- 治療戦略と臨床試験の将来の方向性を議論する.
主な方法:
- 新薬学的クラス (例えば,バソペプチダース阻害剤,アルドステロン合成酵素阻害剤) と新しい分子に関するレビュー.
- 新しい手順や装置 (例えば,動脈バルレセプター刺激,カテーテルによる腎臓消化) の議論.
- 臨床開発の課題と,証拠に基づいたガイドラインの必要性に関する分析.
主要な成果:
- いくつかの新しい薬理学的標的は,前臨床的希望を示していますが,臨床的翻訳は困難です.
- 新しいデバイスと手順は,耐性高血圧の潜在的な代替案を提示します.
- 新型抗高血圧薬の臨床開発は,予想以上に生産性が低下しています.
結論:
- 新薬や新装置は,耐性高血圧管理の有望な道を示しています.
- 新しい介入の効果と安全性を慎重に評価することは極めて重要です.
- 将来の研究は,結果試験と耐性高血圧に対する根拠に基づいたガイドラインに焦点を当てるべきである.
関連する概念動画
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:18Hypertension and Regulation of Blood Pressure
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...